Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AAC Holdings, Inc.AAC · Entity 153765 | Director | May 21, 2019 | May 22, 2019 |
| COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628 | Director · President and CFO | March 01, 2017 | March 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AAC Holdings, Inc.
Report date May 21, 2019 · Filed May 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 160,908 |
Reported balance
After 2019-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-05-21 · Purchase · Acquired 10,000 · Balance 160,908 F1: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.345 to $1.35. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.345 to $1.35. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
COMMUNITY HEALTH SYSTEMS INC
Report date March 01, 2017 · Filed March 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 568,152 |
Ending reported balance
After 2017-03-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-03-01 · Exercise / conversion · Acquired 75,000 · Balance 604,591 Row 2 · 2017-03-01 · Grant · Acquired 16,000 · Balance 620,591 F1: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Row 3 · 2017-03-01 · Tax withholding · Disposed 52,439 · Balance 568,152 |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-02-28 | Direct | 0 |
Reported balance
After 2017-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-03-01 · Exercise / conversion · Disposed 75,000 · Balance 0 F2: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-28 | Direct | 16,000 |
Reported balance
After 2017-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-03-01 · Grant · Acquired 16,000 · Balance 16,000 F3: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.70 · Expires 2018-02-26 | Direct | 60,000 |
Reported balance
Holding disclosure · report date 2017-03-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 60,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.01 · Expires 2019-02-24 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2017-03-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 10,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.32 · Expires 2020-02-23 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2017-03-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 25,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.38 · Expires 2021-02-22 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2017-03-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 25,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.49 · Expires 2022-02-15 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2017-03-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 20,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F2: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F3: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CROSS COUNTRY HEALTHCARE INC
Report date July 21, 2026 · Filed July 21, 2026
Section 16 reporting ended · disclosed 2026-07-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-21 transaction · row 1
1 source rowRow 1 · 2026-07-21 · Disposition to issuer · Disposed 223,312 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2026 Filed Jul 21, 2026 20:09 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Disposition to issuerCommon Stock | 223,312 | $13.25 | $2,958,884.00 |
DisclosureSEC source: 0001012975-26-000690 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2 · kind: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. Read SEC document |
| December 18, 2025 Filed Dec 22, 2025 12:23 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 18,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-25-000963 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,312 F1 · shares: These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 21:08 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 4,800 | $8.17 | $39,209.28 |
DisclosureSEC source: 0001012975-25-000886 · form4.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,632 Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 21:08 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 200 | $8.10 | $1,620.00 |
DisclosureSEC source: 0001012975-25-000886 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,832 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:20 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 9,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011814 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,632 F1 · shares: These restricted shares of common stock will vest on June 1, 2025. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:11 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 5,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012931 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,711 F1 · shares: These restricted shares of common stock will vest on June 1, 2024. Read SEC document |
| August 30, 2022 Filed Aug 30, 2022 21:13 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 1,500 | $25.60 | $38,400.00 |
DisclosureSEC source: 0001062993-22-018883 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,899 Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 21:55 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 2,599 | $17.36 | $45,118.64 |
DisclosureSEC source: 0001062993-22-014200 · form4.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,399 F2 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 21:55 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 7,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014200 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,998 F1 · shares: These restricted shares of common stock will vest June 1, 2023. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:55 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 5,736 | $16.51 | $94,701.36 |
DisclosureSEC source: 0001062993-21-005349 · form4.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,797 F2 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:55 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 6,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005349 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,533 F1 · shares: These restricted shares of common stock will vest June 1, 2022. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 17:06 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 5,000 | $6.61 | $33,050.00 |
DisclosureSEC source: 0001062993-20-003993 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,870 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 18:45 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 2,477 | $6.14 | $15,208.78 |
DisclosureSEC source: 0001012975-20-000527 · edgar.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,870 F2 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 18:45 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 17,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000527 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,347 F1 · shares: These restricted shares of common stock will vest on June 1, 2021. Read SEC document |
| May 14, 2020 Filed May 15, 2020 13:34 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 8,000 | $4.59 | $36,720.00 |
DisclosureSEC source: 0001012975-20-000443 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,431 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.58 to $4.60, inclusive. The reporting person undertakes to provide to Cross Country Healthcare, Inc., any security holder of Cross Country Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 21:10 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 5,000 | $7.65 | $38,250.00 |
DisclosureSEC source: 0001012975-20-000312 · edgar.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,431 F2 · balance_after: The shares reported in this column reflect transactions subsequent to June 1, 2019. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 22:05 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 5,000 | $12.39 | $61,950.00 |
DisclosureSEC source: 0001012975-19-000671 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,306 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.45, inclusive. The reporting person undertakes to provide to Cross Country Healthcare, Inc., any security holder of Cross Country Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 22:05 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 15,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-19-000400 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,306 F1 · shares: These restricted shares of common stock vest in three equal installments. The installments will vest on June 1, 2020, June 1, 2021, and June 1, 2022. Read SEC document |
| June 01, 2019 Filed Mar 13, 2020 21:10 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 1,875 | $7.11 | $13,331.25 |
DisclosureSEC source: 0001012975-20-000312 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,431 F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2019. F2 · balance_after: The shares reported in this column reflect transactions subsequent to June 1, 2019. Read SEC document |
| May 21, 2019 Filed May 22, 2019 18:07 UTC | AAC Holdings, Inc. AAC · Entity 153765 | PurchaseCommon Stock | 10,000 | $1.35 | $13,470.00 |
DisclosureSEC source: 0000899243-19-014334 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,908 F1 · security: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.345 to $1.35. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:30 UTC | AAC Holdings, Inc. AAC · Entity 153765 | GrantCommon Stock | 45,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-011255 · doc4.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,908 F2 · security: The reporting person was granted 45,454 shares of restricted common stock pursuant to the EIP. Subject to the director's continued service on the board, this grant will vest in full on December 31, 2019. This grant was made in respect of the reporting person's continued service as a director in 2019. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:30 UTC | AAC Holdings, Inc. AAC · Entity 153765 | GrantCommon Stock | 45,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-011255 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,454 F1 · security: This reporting person was granted 45,454 shares of common stock pursuant to the AAC Holdings, Inc. 2014 Equity Incentive Plan (the "EIP"). This grant is fully vested and was made in respect of the reporting person's service as a director in 2018. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 21:19 UTC | AAC Holdings, Inc. AAC · Entity 153765 | PurchaseCommon Stock | 25,000 | $2.23 | $55,750.00 |
DisclosureSEC source: 0001209191-18-060369 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Read SEC document |
| August 10, 2018 Filed Dec 31, 2024 22:15 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 4,000 | $9.29 | $37,160.00 |
DisclosureSEC source: 0001062993-24-021325 · form4.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,632 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 17:27 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 9,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000479 · edgar.xml · nonDerivative · entry 4 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,393 F2 · shares: These restricted shares of common stock vest in three equal installments. The installments will vest on June 1, 2019, June 1, 2020, and June 1, 2021. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 17:27 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 1,148 | $12.19 | $13,994.12 |
DisclosureSEC source: 0001012975-18-000479 · edgar.xml · nonDerivative · entry 3 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,369 F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2018. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 17:27 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 895 | $12.19 | $10,910.05 |
DisclosureSEC source: 0001012975-18-000479 · edgar.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,517 F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2018. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 17:27 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 1,168 | $12.19 | $14,237.92 |
DisclosureSEC source: 0001012975-18-000479 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,412 F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2018. Read SEC document |
| May 07, 2018 Filed May 8, 2018 21:16 UTC | AAC Holdings, Inc. AAC · Entity 153765 | PurchaseCommon Stock | 5,000 | $11.91 | $59,550.00 |
DisclosureSEC source: 0001209191-18-028647 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.91 to $11.95, inclusive. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 07, 2018 Filed May 8, 2018 16:28 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 5,000 | $11.14 | $55,700.00 |
DisclosureSEC source: 0001012975-18-000395 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,580 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.02 to $11.24, inclusive. The reporting person undertakes to provide to Cross Country Healthcare, Inc., any security holder of Cross Country Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 22:36 UTC | AAC Holdings, Inc. AAC · Entity 153765 | PurchaseCommon Stock | 5,000 | $9.92 | $49,600.00 |
DisclosureSEC source: 0001209191-18-017769 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.85 to $10.03, inclusive. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 05, 2018 Filed Mar 5, 2018 23:12 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 5,000 | $11.23 | $56,150.00 |
DisclosureSEC source: 0001012975-18-000255 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,580 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.18 to $11.25, inclusive. The reporting person undertakes to provide to Cross Country Healthcare, Inc., any security holder of Cross Country Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 30, 2017 Filed Nov 30, 2017 22:57 UTC | AAC Holdings, Inc. AAC · Entity 153765 | PurchaseCommon Stock | 10,000 | $9.07 | $90,700.00 |
DisclosureSEC source: 0001209191-17-063082 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.02 to $9.08, inclusive. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 15, 2017 Filed Nov 15, 2017 22:17 UTC | AAC Holdings, Inc. AAC · Entity 153765 | PurchaseCommon Stock | 12,000 | $9.93 | $119,160.00 |
DisclosureSEC source: 0001209191-17-060948 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.85 to $9.94, inclusive. The reporting person undertakes to provide to AAC Holdings, Inc., any security holder of AAC Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 28, 2017 Filed Dec 31, 2024 22:15 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | PurchaseCommon Stock | 2,000 | $12.08 | $24,160.00 |
DisclosureSEC source: 0001062993-24-021325 · form4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,632 Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:27 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock (restricted) | 9,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000450 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,560 F1 · security: The restricted shares of common stock will vest in three equal installments. The installments will vest on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 15:24 UTC Amendment | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock (restricted) | 958 | $11.82 | $11,323.56 |
DisclosureSEC source: 0001012975-17-000472 · edgar.xml · nonDerivative · entry 4 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,021 F2 · date: The Form 4, as originally filed on June 5, 2017, incorrectly omitted shares withheld and disposed of for tax purposes. The Form 4, as amended by this Form 4/A, correctly reports such information. F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2017. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 15:24 UTC Amendment | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock (restricted) | 1,249 | $11.82 | $14,763.18 |
DisclosureSEC source: 0001012975-17-000472 · edgar.xml · nonDerivative · entry 3 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,979 F2 · date: The Form 4, as originally filed on June 5, 2017, incorrectly omitted shares withheld and disposed of for tax purposes. The Form 4, as amended by this Form 4/A, correctly reports such information. F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2017. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 15:24 UTC Amendment | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock (restricted) | 2,287 | $11.82 | $27,032.34 |
DisclosureSEC source: 0001012975-17-000472 · edgar.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,228 F2 · date: The Form 4, as originally filed on June 5, 2017, incorrectly omitted shares withheld and disposed of for tax purposes. The Form 4, as amended by this Form 4/A, correctly reports such information. F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2017. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 15:24 UTC Amendment | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock (restricted) | 1,045 | $11.82 | $12,351.90 |
DisclosureSEC source: 0001012975-17-000472 · edgar.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,515 F2 · date: The Form 4, as originally filed on June 5, 2017, incorrectly omitted shares withheld and disposed of for tax purposes. The Form 4, as amended by this Form 4/A, correctly reports such information. F1 · shares: These shares were withheld to satisfy Mr. Cash's tax withholding obligation for restricted stock which vested on June 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:11 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 16,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016529 · doc4.xml · derivative · entry 5 CASH W LARRY · CIK 0001018653 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2027-02-28 F3 · derivative.exercise_date: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:11 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 75,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016529 · doc4.xml · derivative · entry 4 CASH W LARRY · CIK 0001018653 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:11 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 52,439 | $9.19 | $481,914.41 |
DisclosureSEC source: 0001209191-17-016529 · doc4.xml · nonDerivative · entry 3 CASH W LARRY · CIK 0001018653 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,152 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:11 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016529 · doc4.xml · nonDerivative · entry 2 CASH W LARRY · CIK 0001018653 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,591 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:11 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016529 · doc4.xml · nonDerivative · entry 1 CASH W LARRY · CIK 0001018653 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 604,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.